title: Sulfated sericin is a novel anticoagulant influencing the blood coagulation cascade.
abstract: Sulfated sericin's influence on factors in the blood coagulation cascade was investigated to elucidate its anticoagulant mechanism. Prolongation of the prothrombin time (PT) and activated partial thromboplastin time (APTT) were observed in the presence of sulfated sericin. Fluorogenic peptide substrates on thrombin (factor IIa) and factor Xa were used to study the influence of sulfate sericin on their respective activities. Sulfated sericin inhibited neither thrombin nor factor Xa in the presence of antithrombin III (AT III). Gel electrophoresis was used to examine fibrinogen-fibrin conversion by thrombin in the presence of sulfated sericin. FPA and FPB release from fibrinogen by thrombin proceeded in the presence of sulfated sericin. The behavior of polymerization of fibrin monomer (FM) was affected by the presence of sulfated sericin. No initial lag time in the polymerization process was observed by addition of sulfated sericin to FM. This result means that sulfated sericin will interfere in the build-up of normal double-strand fibrils of FM during formation of fibrin fiber. Scanning electron microscopy (SEM) observations supported this inference. The anticoagulant mechanism of sulfated sericin is inferred to interfere with the initial polymerization process of FM.
authors.affiliation: Division of Diabetes, Metabolism and Endocrinology, Department of Medicine, Toho University School of Medicine, 6-11-1 Omori-nishi, Oota, Tokyo 143-8541, Japan.
authors.forename: Masanari
authors.initials: M
authors.lastname: Sano
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Tamada
authors.forename: Kazuki
authors.initials: K
authors.lastname: Niwa
authors.forename: Toshisuke
authors.initials: T
authors.lastname: Morita
authors.forename: Gen
authors.initials: G
authors.lastname: Yoshino